Grey Wolf Health Q2 FY26 net income falls 33.1% to CAD 502,752; revenue rises 11.1% to CAD 10.58 million

• Grey Wolf Health posted Q2 2026 net income of CAD 502,752, down from CAD 751,230 a year earlier.
• Revenue rose 11.1% year over year to CAD 10.6 million, while operating income slipped to CAD 1.22 million.
• IFRS EBITDA fell to CAD 1.89 million; non-IFRS adjusted EBITDA declined 7.5% to CAD 2 million.
• Pharmacy revenue climbed 9.3% to CAD 6.7 million, while Animal Health revenue increased 14.2% to CAD 3.9 million.
• Management cited investments in people, a new ERP system, and a new compounding facility; appointed a new VP of Sales & Marketing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grey Wolf Health Corp. published the original content used to generate this news brief via CNW (Ref. ID: 202608251700CANADANWCANADAPR_C5778) on August 25, 2026, and is solely responsible for the information contained therein.